Trigger Point
Trigger Point, licence 80118489: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Ballistic Labs
- NPN or DIN-HM
- 80118489
- Status
- Active licence
- Licence date
- 9 May 2022
- Revision date
- 21 June 2022
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-Citrulline Source : Malate de citrulline | 1.5 g | Not calculated |
| 1,2,3-propanetriol Source : Glycérol | 1.0 g | Not calculated |
| L-Tyrosine Source : L-Tyrosine | 750.0 mg | Not calculated |
| Choline Source : Bitartrate de choline | 250.0 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 5.0 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 100.0 mg | Not calculated |
| D-Glucuronolactone Source : D-Glucuronolactone | 150.0 mg | Not calculated |
| 1,3,7-Triméthylxanthine Source : Caféine | 200.0 mg | Not calculated |
| L-alpha-Glycérophosphorylcholine Source : Alfoscérate de choline | 250.0 mg | Not calculated |
| Niacine Source : Niacinamide | 25.0 mg | Not calculated |
| Glycine, N-(aminoiminométhyl)-N-méthyl-, monohydrochlorure Source : Chlorhydrate de créatine | 750.0 mg | Not calculated |
| 1-Carboxy-N,N,N-sel interne de triméthylméthanaminium Source : Bétaïne | 2.5 g | Not calculated |
Non-medicinal ingredients
Farine de riz brun, Phosphate de calcium, tribasique, Saveur, Sucralose, Stéarate de magnésium, Acide citrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 0.5 Mesures | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of/An antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps (temporarily) to enhance (physical) energy. Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to reduce tiredness and fatigue. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Used (temporarily) as a mild diuretic. Helps (temporarily) to support/promote mental sharpness/alertness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80118489
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.